30 Posts Not To Miss From AACR24!
The AACR Annual Meeting 2024 was held from April 5th to 10th in San Diego, USA. It is the focal point of the cancer research community, where scientists, clinicians, other healthcare professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. Our team at OncoDaily has collected 30 posts that you should not miss from this event!
A few tips for AACR24 (whether this is your 1st meeting or you’re a veteran!):
- Be open
- Think about the future
- Connect
American Association for Cancer Research
AACR24 Highlights: Vision for the Future—Program Chairs, Keith T. Flaherty and Christina Curtis moderate the final Plenary Session, featuring summaries of cutting-edge science from Mikala Egeblad, Melissa A. Simon, and Ryan B. Corcoran.
Heading to AACR24 and try to navigate all the new ADC data? Must read:
- ADC dogma
- ADC toxicity
- ADC payload exposure
- ADC targets
- ADC clinical development
Thank you, the American Association for Cancer Research, for the opportunity to co-moderate this AACR24-ASCO joint session with Dr. Philip Greenberg on the detection and treatment of minimal residual disease (MRD). Many thanks to our expert panelists for their dynamic and insightful presentations: Drs. Luis Diaz, Max Diehn and Angie DeMichele.
Where does the American Association for Cancer Research AACR24 Plenary Chair work with the American Society of Clinical Oncology (ASCO) ASCO24 Plenary Chair?
Thrilled to work alongside the world-renowned Dr. Melissa Johnson, my clinic day partner. as we have exhilarating discussions on Precision Medicine and picking rare gene fusion needles from the haystack. Dr. MJ picked one needle today.
Save the date: American Society of Clinical Oncology (ASCO) Plenary Series, April 30, 2024. Dr. Melissa Johnson Chairs the ASCO plenaries on KRAS G12C.
While at AACR24, I spoke with Mostafa Nasr about his research on prostate cancer metastasis and dormancy. Watch the video to learn more about his work!
A few physician and scientist colleagues (a bunch of guys) went out on San Diego bay for lunch this afternoon in Coronado. I’m taking other colleagues who can make it out in the late afternoon as well today after stopping by some more posters at the convention center.
Some of us here are from Rhode Island (Legorreta Cancer Center at Brown University) and appreciate the opportunity to see the beauty of San Diego Bay. We want the younger colleagues to know that you can enjoy your career and remember to keep a work-life balance.
American Association for Cancer Research (AACR)
Lucile Adams-Campbell presents the AACR Distinguished Public Service Award posthumously to Worta McCaskill-Stevens during the AACR24 Opening Ceremony. Dr. McCaskill-Stevens’ son, Saleh Stevens, accepted the award on her behalf.
Day 4 of AACR24. So happy to present my work on lung cancer persister evolution trajectories to KRAS inhibitor. Got some wonderful discussions. Thanks to support from sponsors: Amgen, NCI F32 Fellowship and Ludwig Cancer research foundation.
FLAURA2: On-treatment plasma EGFR clearance prognostic but not predictive benefit with osimertinib and Chemotherpay vs Osi alone by P. Jänne at AACR24.
Thank you, Pelotonia and Victoria’s Secret for sponsoring an excellent Women empowerment workshop.
Belal N. Sabbah (Saudi Arabia)
Thrilled to have showcased our research at AACR24 today! It was truly rewarding to engage with and gain insights from peers and mentors globally. The pursuit of cancer research is vital in saving lives. Thankful to the AACR for organizing this.
Great turnout for the AACR Foundation Run for Research 5k…over 900 runners this year!
Easier to get a ticket for a Taylor Swift concert than to find a seat at the AACR24 Next Generation ADC session!
Twenty-six years after founding AACRSSP, Anna D. Barker is still the driving force behind the AACR24 Scientist to Survivor Program. Thanks, Ann, for your vision in bringing together the scientific, cancer survivor, and patient advocacy communities to drive progress against cancer.
Jakob Nikolas Kather (Germany)
It was such an honor to give a plenary opening lecture on AI in cancer research at AACR24, alongside some of today’s most brilliant scientists, including Aviv Regev from Genentech, Benjamin Cravatt from Scripps Research and Nobel Laureate, Carolyn Bertozzi from Stanford.
Thanks to the visionary program chairs Christina Curtis and Keith Flaherty!
Nicholas Huntington (Australia)
Truely remarkable amount of NK cell therapy innovation and clinical translation from Katy Rezvani and her wonderful team. Exciting updates on NK cells engineered to also respond to investigational CD3 engagers in Haematological Malignancies.
New AACR President Dr. Patricia LoRusso gets right to the heart of things, “I have a feeling many of you are here because of the recent cuts to the NIH budget.” BINGO! At the same time, advocacy is used to doing amazing things with very little money so… it’s possible.
What is the role of the TME in lung cancer evolution? We are excited to share our new TRACERx paper “Spatial Architecture of Myeloid and T Cells Orchestrates Immune Evasion and Clinical Outcome in Lung Cancer” at AACR24, out in Cancer Discovery today.
So proud of and absolutely amazed by Mikala Egeblad’s closing plenary, highlighting all the incredible works in basic cancer science and translational research. My honor to be her former trainee and got to be her team with Chang Jiang, Eneda Toska and Jelani Zarif.
Timely AACR24 with the 1st approval of an agnostic ADC for HER2-positive cancers. Debate on criteria. My 2 cents: the true HER2 positive are hard to miss. It’ll be corroborated by ERBB2 gene amplification on other tests. Approval is the key to access.
My presentation at AACR24 on the different toxicities that EAO cancer patients face (physical, mental/emotional, financial, time) is aligned with Kimmie Ng’s points on the unique challenges of this population.
Great first AACR conference. I enjoyed presenting my research and had the pleasure of meeting and learning from multiple scholars in diverse areas of cancer research from all over the world. I am also thankful for AACRMICR honoring me with a Scholar in Cancer Research Award!
I had the honor of meeting a hero in the field of oncology and immunotherapy Dr. Steven Rosenberg. Dr. Rosenberg’s AACR Award for Lifetime Achievement in Cancer Research presentation was a work of art, thank you for inspiring us!
Reflecting on AACR24:
- Phenomenal cancer science and medicine
- Outstanding leadership from AACR and Kimryn Rathmel
- Best of all – the greatest community! I so loved seeing all the connections
Our work is most fun when shared. See y’all at AACR25 (or sooner!)
Back to Boston from AACR24. Energized by the science, the friends, the new connections & ideas. Inspired by the great presentations and posters. Raises hope to see so many brilliant minds working together to end cancer. Thanks to all those that reached out or stopped for a chat!
As I head home from AACR. I can’t help but reflect on how amazing it was to be a mentor for the Scientist to Survivor program. I made new friends, learned about the future of cancer research and am energized to do more!
Thank you, AACR, for another terrific annual meeting. We enjoyed sharing our research, learning from others, and connecting with the community of people working to advance Cancer Research. We look forward to seeing you again next year!
My highlight of AACR24 was meeting in person, Orazio Vittorio- the Team Leader of Metal Targeted Therapy and Immunotherapy. You guys are doing amazing work in copper chelation therapies to reprogram the TME. We will keep working together! Safe trip to Australia my friends!
American Association for Cancer Research
Thank you to everyone who engaged in the online conversation for the AACR Annual Meeting 2024 in San Diego, including our AACR24 Social Media Ambassadors.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023